FDA Expects STD Claims Enforcement To Deter Future Violations
This article was originally published in The Tan Sheet
Executive Summary
FDA will consider prosecuting executives of firms making unapproved sexually transmitted disease treatment claims for OTC drugs and nutritional products, the targets of its latest enforcement sweep.